Beth is a pharmaceutical executive with over 17 years of experience in early commercialization, new product planning, marketing, and life cycle management. She has a passion for patients and the rare disease space, and is well-known and respected for her work managing brands and the relationships formed with patient groups and disease-state thought leaders.
Beth has extensive experience in neurology and CNS, diabetes, and rare diseases. She excels at aligning and leading cross-functional teams within healthcare manufacturers to develop market-leading strategies supported by strong financial and operational plans. She has authored over twenty strategic marketing and launch plans for various products, and has overseen the launch of pharmaceutical products and managed multiple agencies and vendors. Beth is skilled at forming and running market research and advisory boards, and excels at engaging key thought leaders in strategic and tactical discussions.